DIAGNOS Hires Investor Relation Firm Arrowhead Business and Investment Decisions, LLC and Grants Stock Options

BROSSARD, QUEBEC--(Marketwired - Nov. 29, 2017) - DIAGNOS Inc. ("DIAGNOS", "the Corporation" or "we") (TSX VENTURE:ADK)(OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an agreement with Arrowhead Business and Investment Decisions LLC ("Arrowhead") of New York, NY, with the main objective of raising DIAGNOS profile among targeted U.S. institutional and private investors, and a stock options grant to one Director.